Chemotherapy with paclitaxel for lung metastases of cystic adenoid carcinoma. A case report and review of the literature;Chimiothérapie par paclitaxel dans les métastases pulmonaires des carcinomes adénoïdes kystiques: A propos d'un cas et revue de la littérature

Revue de Pneumologie Clinique

Volumn 59, Issue 6, 2003, Pages 371-374

  Perrot, E ^a,b   Davy, N ^a   Poubeau, P ^a   Arvin Berod, C ^a  

^a CHU   (France)

^b NONE   (France)

Author keywords

Chemotherapy; Cystic adenoid carcinoma; Lung metastases; Paclitaxel

Indexed keywords

PACLITAXEL;

ADENOID CYSTIC CARCINOMA; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; LUNG METASTASIS; PLEURA METASTASIS; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, ADENOID CYSTIC; FEMALE; HUMANS; LUNG NEOPLASMS; PACLITAXEL; PLEURAL NEOPLASMS; SALIVARY GLAND NEOPLASMS; TREATMENT OUTCOME;

EID: 0842278660     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. nd ed. Berlin: World Health Organization, 1991:21.
2. Spencer H. Bronchial mucous gland tumors. Virchows Arch [A] 1979;383:101-15.
3. Spiro RH, Huvos AG, Strong EW. Adenoid cystic carcinoma of salivary origin. A clinico-pathological study of 242 cases. Am J Surg 1994;128:512-20.
4. Inoue H, Iwashita A, Kanegae H, Higuchi K, Fijunaga Y, Matsumoto I. Peripheral pulmonary adenoid cystic carcinoma with substantial extension to the proximal bronchus. Thorax 1991;46:147-8.
5. Grillo HC, Mathisen DJ. Primary tracheal tumors: treatment and results. Ann Thorac Surg 1990;49:69-77.
6. Chatelut E, Dezeuze A, Lavit M, Chevreau C, Pujol A, Boneu A, et al. Prediction of carboplatin clearance from morphological and biological patient caracteristics. Bull Cancer 1995;82:946-5.
7. Fields JN, Rigaud G, Emani BN. Primary tracheal tumours. Treatement and results. Cancer 1989;63:2429-33.
8. Simpson JR, Matsuba HM, Thawley SE, et al. Improved treatment of salivary adenocarcinomas: planed combined surgery and irradiation. Laryngoscope 1986;96:904-7.
9. Harrison LB, Armstrong JG, Spiro RH, et al. Post-operative radiation therapy for major salivary gland malignancies. J Surg Oncol 1990;45:52-5.
10. Rentschler R, Burgess MA, Byers R. Chemotherapy of malignant major salivary gland neoplasms: a 25-year review of M.D. Anderson Hospital Experience. Cancer 1977;40:619-24.
11. Schramm VL, Srodes C, Myers EN. Cisplatin therapy for adenoid cystic carcinoma. Arch Otolaryngol 1981;107739-41.
12. Licitra L, Marchini S, Spinazzè S, Rossi A, Rocca A, Grandi C, et al. Cisplatin in advanced salivary gland carcinoma: a phase 11 study of 25 patients. Cancer 1991;68:1874-7.
13. De Haan D, De Mulder PHM, Vermoken JB, Schornagel JH, Vermey A, Vermeij J. Cisplatin-based chemotherapy in advanced carcinoma of the head and neck. Head Neck 1992;14:273-7.
14. Tannock IF, Sutherland DJ. Chemotherapy for adenocystic carcinoma. Cancer 1980;46:452-4.
15. Vermorken JB, Verweij J, De Mulder PH, Cognetti F, Clavel M, Rodenhuis S, et al. Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group. Ann Oncol 1993;4:785-8.
16. Airoldi M, Bumma C, Bertetto O, Gabriele P, Succo G, Pedani F. Vinorelbine treatment of salivary gland carcinomas. Bull Cancer 1998;85:892-4.
17. Creagan ET, Woods JE, Schutt AJ, O'Fallon JR. Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of advanced non-squamous cell head and neck cancer. Cancer 1983;52:2007-10.
18. Dreyfuss AI, Clark JR, Fallon BG, Posner MR, Norris CM, Miller D. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer 1987;15:2869-72.
19. Creagan ET, Woods JE, Rubin J, Schaid DJ. Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck. Cancer 1988;62:2313-9.
20. Triozzi PL, Brantley A, Fisher S, Cole TB, Crocker I, Huang AT. 5-fluorouracil, cyclophosphamide, and vincristine for adenoid cystic carcinoma of the head and neck. Cancer 1987;59:887-90.
21. Dimery IW, Legha SS, Shirinian M, Ki-Hong W. Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma. J Clin Oncol 1990;8:1056-62.
22. Farhat F, Kattan J, Culine S, Bekradda M, Droz JP. Efficacité de l'association 5-fluorouracile, adriamycine et cisplatinum (FAP) dans le traitement des cylindromes métastatiques. A propos d'un cas avec revue de la littérature. Bull Cancer 1994;81:47-50.
23. Hill ME, Constenla DO, A'Hern RP, Henk JM, Rhys-Evans P, Breach N, et al. Cisplatin and 5-FU for symptom control in advanced salivary gland carcinoma. Oral Oncol 1997;33:275-8.
24. Spiers AS, Esseltine DLW, Ruckdeschel JC, Davies JNP, Horton J. Metastatic adenoid cystic carcinoma of salivary glands: case reports and review of the literature. Cancer Control J 1996;3:336-42.
25. Airoldi M, Pedani F, Succo G, Gabriele AM, Ragona R, Marchionatti S, et al. Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatine, in patients with recurrent salivary gland malignancies. Cancer 2001;91:541-7.
26. Airoldi M, Pedani F, Succo G, Gabriele AM, Ragona R, Marchionatti S, et al. Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res 2000;20:3781-4.